Sex differences in association between cognitive impairment and clinical correlates in Chinese patients with first-episode drug-naïve schizophrenia

[1] Riecher-Rossler A(2018)Sex and gender differences in schizophrenic psychoses-a critical review Arch Womens Ment Health 21 627-648

[2] Butler S(2018)Gender differences in schizophrenia: a multicentric study from three Latin-America countries Psychiatry Res 266 65-71

[3] Kulkarni J(2019)Does gender influence outcome in schizophrenia? Psychiatr Q 90 173-184

[4] Caqueo-Urizar A(2016)The psychology of schizophrenia: implications for biological and psychotherapeutic treatments J Nerv Ment Dis 204 564-569

[5] Fond G(2015)Elevated C-reactive protein is associated with sensory gating deficit in schizophrenia Schizophr Res 165 94-96

[6] Urzua A(2020)A synergistic effect between family intervention and rTMS improves cognitive and negative symptoms in schizophrenia: a randomized controlled trial J Psychiatr Res 126 81-91

[7] Boyer L(2019)Cognitive deficit in schizophrenia: an overview Psychiatr Danub 31 139-142

[8] Seeman MV(2018)Subcortical association with memory performance in schizophrenia: a structural magnetic resonance imaging study Transl Psychiatry 8 20-124

[9] Dewan MJ(2019)Cognitive functioning as a predictor of response to comprehensive cognitive remediation J Psychiatr Res 113 117-420

[10] Micoulaud-Franchi JA(2018)The impact of aging, psychotic symptoms, medication, and brain-derived neurotrophic factor on cognitive impairment in japanese chronic schizophrenia patients Front Psychiatry 9 232-250

[1] Riecher-Rossler A(2018)Sex and gender differences in schizophrenic psychoses-a critical review Arch Womens Ment Health 21 627-648

[2] Butler S(2018)Gender differences in schizophrenia: a multicentric study from three Latin-America countries Psychiatry Res 266 65-71

[3] Kulkarni J(2019)Does gender influence outcome in schizophrenia? Psychiatr Q 90 173-184

[4] Caqueo-Urizar A(2016)The psychology of schizophrenia: implications for biological and psychotherapeutic treatments J Nerv Ment Dis 204 564-569

[5] Fond G(2015)Elevated C-reactive protein is associated with sensory gating deficit in schizophrenia Schizophr Res 165 94-96

[6] Urzua A(2020)A synergistic effect between family intervention and rTMS improves cognitive and negative symptoms in schizophrenia: a randomized controlled trial J Psychiatr Res 126 81-91

[7] Boyer L(2019)Cognitive deficit in schizophrenia: an overview Psychiatr Danub 31 139-142

[8] Seeman MV(2018)Subcortical association with memory performance in schizophrenia: a structural magnetic resonance imaging study Transl Psychiatry 8 20-124

[9] Dewan MJ(2019)Cognitive functioning as a predictor of response to comprehensive cognitive remediation J Psychiatr Res 113 117-420

[10] Micoulaud-Franchi JA(2018)The impact of aging, psychotic symptoms, medication, and brain-derived neurotrophic factor on cognitive impairment in japanese chronic schizophrenia patients Front Psychiatry 9 232-250